首页 | 本学科首页   官方微博 | 高级检索  
     


A randomized,observer-blind,vehicle-control,multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitis
Authors:Alex Alexopoulos MD  PhD  Maria Dakoutrou MD  Msc  Lamprini Nasi MD  PhD  Ioanna Thanopoulou MD  Talia Kakourou MD  PhD  Louiza Kontara MD  PhD  Nikolaos Douladiris MD  PhD  Maria Galani MD  Paraskevi Xepapadaki MD  PhD  Chrysoula Doxani MD  PhD  Theodoros Mprotsis PhD  Elias Zintzaras PhD  Nikolaos G. Papadopoulos MD  PhD  Christina Kanaka-Gantenbein MD  PhD  George P. Chrousos MD  PhD
Affiliation:1. Pediatric Dermatology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, “Aghia Sophia” Children's Hospital, Athens, Greece;2. Pediatric Department, Kingston Hospital, London, UK;3. Allergy Department, Second Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece;4. Department of Biomathematics, School of Medicine, University of Thessaly, Larissa, Greece;5. Department of Biomathematics, School of Medicine, University of Thessaly, Larissa, Greece

The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA;6. First Department of Pediatrics, National and Kapodistrian University of Athens, “Aghia Sophia” Children's Hospital, Athens, Greece;7. First Department of Pediatrics, National and Kapodistrian University of Athens, “Aghia Sophia” Children's Hospital, Athens, Greece

University Research Institute of Maternal and Child Health and Precision Medicine and UNESCO Chair on Adolescent Health Care, National and Kapodistrian University of Athens, “Aghia Sophia” Children's Hospital, Athens, Greece

Abstract:
Keywords:atopic dermatitis  child  ectoine  eczema
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号